Latest Interviews
“We have tremendous growth opportunities, particularly in the western region where many of the larger mines are located. The schedule and demand in the mining sector is aggressive and I don’t see it slowing down anytime soon.”
59979
"The dynamics of competition are highly fluid today, and I believe the industry will find success in well-defined, specifically targeted products rather than by competing with the same undifferentiated products."
59977
"As more robust drug candidates are emerging, I am willing to bet that we will have the first NASH drug approved in 2023."
59972
"We are looking into new ways to reap the benefits of artificial intelligence, particularly on the clinical side. On the physical side, Meteoric Biopharmaceuticals will have a new factory and lab up and running by the end of 2024, that will work on advanced fermentation processes."
59970
"We now offer end-to-end modular technical services, encompassing both pre-clinical and clinical development of biosimilars addressing global regulatory requirements."
59968
"The whole point of our work in the country is to empower Congolese people and give them a sense of achievement. AMS only hires locally."